Cadila Healthcare Ltd Q3FY21 consolidated net profit higher at Rs. 527.2. crore
Posted On:
CADILA HEALTHCARE LTD. has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.3823.1 crores during the period ended December 31, 2020 as compared to Rs.3847.5 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.527.2 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.473.4 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.5.15 for the period ended December 31, 2020 as compared to Rs.4.62 for the period ended September 30, 2020.
Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore
SECTIONS
Last Updated: Feb 05, 2021, 04:02 PM IST
Share
Synopsis
The company had posted a net profit of Rs 373.9 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE.
Consolidated revenue of the company stood at Rs 3,795.6 crore for the quarter under consideration. It was Rs 3,638.1 crore for the same period a year ago, it added.
Related
NSE
Drug firm
Cadila Healthcare on Friday reported a 41 per cent rise in its consolidated net profit to Rs 527.2 crore for the quarter ended December 2020 on account of robust sales in all segments.
Zydus Cadila s net profit up 41 in Q3 to Rs 527 crore-ANI businessworld.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessworld.in Daily Mail and Mail on Sunday newspapers.
Cadila Healthcare Q3 Net Profit Up 41% To Rs 527 Crore moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Zydus Cadila s net profit up 41 pc in Q3 to Rs 527 crore ANI | Updated: Feb 05, 2021 17:07 IST
Ahmedabad (Gujarat) [India], February 5 (ANI): Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the corresponding quarter of previous year.
Consolidated revenues moved up by 4 per cent to Rs 3,796 crore consolidated net sales by 6 per cent to Rs 3,754 crore. Earnings before interest, depreciation and tax (EBIDTA) were up by 16 per cent to Rs 807 crore.
The company s business in India, which comprises human health formulations business, consumer wellness business and animal health business posted 20 per cent growth in the quarter ended December 2020 with revenues of Rs 1,643 crore.